Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 7/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | HMOX2 | P30519 | 1/20 | 0.46 |
| ▸ | CRYZ | Q08257 | 1/20 | 0.46 |
| ▸ | VAT1 | Q99536 | 1/20 | 0.46 |
| ▸ | RTN4 | Q9NQC3 | 1/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 12/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GALR2 | O43603 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29765838 | 0.91 | KRAS (0.58) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16637475 | 0.91 | KRAS (0.58) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16637036 | 0.89 | KIT (0.45) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16637034 | 0.86 | KIT (0.37) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16637084 | 0.85 | CYP1A2 (0.43) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL19681369 | 0.79 | ACHE (0.44) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL19681380 | 0.79 | KRAS (0.63) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16647016 | 0.78 | KRAS (0.70) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL29765950 | 0.78 | KRAS (0.70) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL16637051 | 0.78 | KRAS (0.64) | KRASEGFRHMOX2CRYZVAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9840516-B2 | Substituted quinazolines as inhibitors of KRAS G12C | ARAXES PHARMA LLC (US) | 2017-12-12 | — | — | US | disclosed |